Back to search
FDAFDA · Food and drugs·Recall number D-789-2013

Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL

Published July 17, 2013 · Recall initiated: May 29, 2013

Summary

FDA records drug Class II recall D-789-2013, published July 17, 2013 and initiated May 29, 2013. Recalling firm: Lowlite Investments, Inc. D/B/A Olympia Pharmacy; Status: Ongoing; Reported quantity: 1; Lot: A5011 Exp 7/10/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Distributor
Nationwide and PR
Lot
A5011 Exp 7/10/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL recalled?

Yes. FDA published recall D-789-2013 on July 17, 2013. Reported hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit